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Human T lymphocytes that express the T4 (CD4) cell-surface antigen play a
central role in the regulation of immune responses. T4+ lymphocytes are,
however, a functionally heterogeneous population ofcells that can be subdivided
by the mAb anti-2H4, into the T4', 2H4+ subset that induces suppressor activity
of the T8+ suppressor T cells, and the T4+, 2H4- T cell subset with helper
function (1). Biochemical analysis has shown that the 2H4 antigens are members
ofa family ofhigh molecularweight cell surfaceglycoproteins known asleukocyte
common antigens (LCAs), T200 or CD45 (2). While some anti-LCA mAbs react
with all forms of LCAs, which are resolved into four or more proteins by SDS-
PAGE, other anti-LCA mAbs, including anti-2H4, react only with a subset of
these proteins (2-4). In functional studies, anti-2H4, but not anti-LCA mAbs
that are reactive with all LCA members, has been shown to block the induction
ofsuppression by T4+, 2H4'cells (5). These studies suggestthat the 2H4 epitope
may be directly involved in the induction ofsuppressor function. It is, therefore,
important to establish the molecular basis of the 2H4 epitope expression to
understand the function ofthe suppressor-inducer T cell subset.
Recently, it was demonstrated (6, 7) that the genetic basis ofthe heterogeneity
of the human LCAs is the differential usage of three exons of the single LCA
gene. The exons termed A, B, and C, which are differentially used, encode 66,
47, and 48 amino acids, respectively, of the amino-proximal end of the LCA
molecules (6). In a previous report (6), cDNA clones corresponding to three
LCA structures were isolated, and the existence of at least two more forms of
LCA mRNA was shown by Northern hybridization experiments. Since then, we
have isolated a cDNA clone that corresponds to one of the predicted structures.
In this communication, we study the molecular basis ofthe 2H4 epitope expres-
sion using these cDNA clones encoding four of the LCAs.
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Structures of the LCA cDNA subclones used for in vitro RNA synthesis. Thin
lines indicate the vector sequence (pSP65 for LCA.6, LCA.260, and LCA.1, and pSP64 for
LCA.338), and boxes represent LCA cDNA sequences. The arrows indicate the initiation sites
and the direction of RNA synthesis by SP6 RNA polymerase. ATG indicates the initiation site
of protein synthesis. Small boxes labeled A, B, or C, are encoded by LCA exons A, B, or C,
respectively. Solid boxes indicate the sequences encoding the transmembrane peptide. The
four cDNA inserts are incomplete in that they lack the 3' portions of the protein coding
sequences. Therefore, common 3' ends were created by linearizing the plasmid DNAs by
digesting with the restriction enzyme Bgl II.
Materials and Methods
Monoclonal Antibodies.
￿
The murine mAbs, anti-2H4, GAP 8.3, and HB7 have been
described previously (1, 4, 8).
Plasmid Constructions.
￿
The LCA cDNA clones, LCA.6, LCA.260, and LCA.1, were
described previously (6). A fourth LCA cDNA clone, LCA.338, was characterized by
restriction site mapping and sequence determination (9) (our unpublished results). The
LCA.338 cDNA has the same NH2-terminal amino acid coding sequence as LCA.6 except
that it lacks the nucleotides that exactly correspond to exon C (6) (Fig. 1). These cDNAs
sequences were subcloned into the Eco RI site of the plasmid vector pSP65 or pSP64 (10)
such that the 5' ends ofthe LCA cDNAs were proximal to the SP6 polymerase transcrip-
tion start site.
In Vitro Synthesis of LCA mRNA.
￿
RNA transcripts were synthesized in a reaction (0.1
ml) containing 10 Ag of template SP6 .LCA DNA linearized with the restriction enzyme
Bgl II, 40 mM Tris-HC1 (pH 7.5), 6 MM MgC12, 2 mM spermidine, 10 mM DTT, 1
mg/ml acetylated-BSA, 1 U/A1 RNasin (Promega Biotec, Madison, WI), 0 .5 mM each
rNTP, 0.5 mM G(5')ppp(5')G (Pharmacia Fine Chemicals, Piscataway, NJ), and 40 U SP6
RNA polymerase (Promega Biotec) for 2 h at 40°C. The full-length RNA products were
purified by agarose gel electrophoresis, extracted four times with phenol, precipitated
with ethanol, and dissolved in H2O.
In Vitro Translations.
￿
In vitro synthesized LCA mRNAs or Brome Mosaic VirusRNA
(Promega Biotec) were translated in a nuclease-treated rabbit reticulocyte lysate according
to the procedure recommended by the supplier (Promega Biotec). The translation cocktail
(0.1 ml) contained 70 Al of reticulocyte lysate, 20 AM each of 19 amino acids, 1 AM [s'Sl-
methionine (1,100 Ci/mmol), (New England Nuclear, Boston, MA), 1 U/Al RNasin, 2 jug
in vitro synthesized RNA, and were incubated for 60 min at 30°C.
Preformed Immune Complex Generation and Immunoprecipitations.
￿
Preformed complexes
between mAbs and rabbit anti-mouse IgG were prepared by incubating 10 A1 of ascites
fluid with 12 Ag ofpurified rabbit anti-mouse IgG (Jackson Immunoresearch Laborato-
ries, West Grove, PA) for 4 h at 4'C. Complexes were recovered by centrifugation
(13,000 g for 3 s), and washed four times in cold (4°C) wash buffer (1% (vol/vol) Triton
X-100, 150 mM NaCl, 50 mM Tris-HCl (pH 7 .5), 5 mM EDTA, 1 mg/ml BSA, 0.1STREULI ET AL.
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NaNs). Translation cocktails were diluted 20-fold with cold wash buffer containing the
following protease inhibitors: 0.2 mg/ml soybean trypsin inhibitor, 2 Ag/ml antipain, 2
,ug/ml chymostatin, 0.4 juM leupeptin, 0.3 IM pepstatin, 0.3 uM iodoacetamide, 0.2
TIU/ml aprotinin, and 1 mM PMSF. A 0.2-ml aliquot of the diluted translation cocktail
was added to the preformed complexes of anti-2H4 or HB7 antibody and incubated at
4'C for 16 h. Immune complexes were washed four times with cold wash buffer, dissolved
in 50 ul of sample buffer (250 mM Tris-HCl, pH 6.8, 2% [wt/vol] SDS, 5% [vol/vol]
glycerol, 0.002% [wt/vol] bromophenol blue, and 1% [vol/vol] 2-ME), and boiled for 4
min. Samples were electrophoresed on a 10% SDS-polyacrylamide gel, and autoradi-
ographed as described previously (11).
Radiolabeling and Immunoprecipitation ofCell Surface Molecules.
￿
Human T4+ cells were
purified from the blood of healthy volunteer donors as previously described (1). 108 T4'
cells were labeled with 1 MCi of
￿
1 by peroxidase-catalyzed iodination (12), and solubi-
lized as described previously (11). In the case of preclearing, 0.2 ml of the cell lysate
(equivalent of 2 x 108 T4* cells) was precleared five times with either 20 ill of the GAP
8.3 antibody (ascites) bound to 60,ul of a 50% (vol/vol) protein A-Sepharose suspension
(Pharmacia Fine Chemicals) or with 50 ;1 of anti-2H4 antibody crosslinked to Sepharose
413 (equivalent to 25 kg of purified anti-2H4 antibody). For immunoprecipitation, the
untreated or the precleared cell lysates were incubated for 3 h with either 5 Al of the
GAP 8.3 antibody or with 20 Il of anti-2H4 antibody crosslinked to Sepharose 413. 20 wl
of a 50% (vol/vol) protein A-Sepharose suspension were then added to the GAP 8.3
precipitations, and the mixture was incubated for 60 min. The antibody-bound beads
were washed two times with 0.5% Triton X-100 in 10 mM Tris-HCl (pH 7.4), 140 mM
NaCl, three times with 0.5% deoxycholate in 10 mM Tris-HCl (pH 8.2), 140 mM NaCl,
and once with 10 mM Tris-HCl (pH 8.0). Immune complexes were analyzed in reducing
conditions by SDS-PAGE on a 6% gel followed by autoradiography (11).
Results and Discussion
The anti-2H4 antibody precipitates proteins of 220 and 200 kD, while the
mAbs that react with all LCAs, e.g., GAP 8.3 (4), precipitate 190- and 180-kD
proteins as well as 220- and 200-kD proteins from surface-labeled human T4'
cells (4; also see Fig. 3). To study the structural basis for the differential
expression of the 2H4 epitope, we generated individual LCA proteins in vitro
using cloned human LCA cDNAs (6, 10, 13). The structures of the LCA cDNAs,
and the segments of cDNA sequences encoded by the differentially used exons,
called exons A, B, or C, are schematically shown in Fig. 1 . The cDNA sequences
were individually inserted into the plasmid vector pSP65 or pSP64 (10) at a
restriction site immediately 3' of the promoter site for the bacteriophage SP6
RNA polymerase. The orientation of the inserts was chosen so that the RNAs
synthesized by the SP6 polymerase encode LCA proteins. The four SP6.LCA
cDNA plasmids were linearized at the unique Bgl 11 site, and were used as
templates for synthesis of LCA RNA by SP6 RNA polymerase. Since all the LCA
cDNA plasmids were linearized at the Bgl 11 site, the resulting LCA RNAs have
exactly the same 3' end, regardless of the 3' end points of cDNA inserts (see
Fig. 1). LCA RNAs were purified and used to synthesize LCA proteins in a
rabbit reticulocyte lysate system in the presence of [s5S]methionine. The in vitro
synthesized LCA proteins differ from each other only by the inclusion or
exclusion of the amino acids encoded by exons A, B, or C. These proteins are
truncated in that they contain only the extracellular portion of the LCA mole-
cules. The translation products of the LCA RNAs, as well as the control Brome
Mosaic Virus (BMV) RNA are shown in Fig. 2A.1570
￿
STREULI ET AL .
￿
BRIEF DEFINITIVE REPORT
FIGURE 2 . Immunoprecipi-
tation of in vitro synthesized
LCA molecules using the anti-
2H4 antibody . Truncated
LCA proteins or controlBMV
proteins were synthesized in a
rabbit reticulocyte lysate sys-
tem in the presence of [
ssSl-
methionine (A), and immuno-
precipitated with anti-2114 an-
tibody (B) . Samples are (1)
BMV, (2) LCA.338, (3)
LCA.1, (4) LCA.260, and (5)
LCA.6 .
Immunoprecipitation studies using the in vitro synthesized LCA proteins were
carried out to determine which formsof theLCA molecules couldbe precipitated
by anti-2114 antibody . As seen in Fig. 2B, the anti-2114 antibody precipitates the
LCA.6 andLCA.338 proteins, but does not precipitate theLCA.1 and LCA.260
proteins, or theBMV products . The finding that only LCA proteins that contain
the A exon amino acids were precipitated by anti-2114 argues that the peptide
encoded by exon A is necessary for anti-2114 antibody binding . The control
mAb, HB7, with an unrelated specificity but of the same IgGI isotype as anti-
2H4, did not precipitate any of the in vitro synthesized proteins (data notshown) .
The Gap 8 .3 antibody and several other anti-LCA mAbs did not precipitate any
of the LCA proteins synthesized in vitro (data not shown), suggesting that these
proteins lack the necessary modification and/or conformation to allow binding
by most anti-LCA mAbs . The simplest interpretation of the requirement ofexon
A expression for the binding of the anti-2114 antibody to LCA molecules is that
the 2114 epitope is encoded by the A exon . However, we cannot exclude the
possibility that the presence of theA exon segment indirectly affects the binding
of anti-2114 to the actual 2114 epitope residing outside of theA exon segment .
The finding that the expression ofLCA exon A is required for the expression
of the 2114 epitope correlates well with our previous Northern hybridization
results using an exon A-specific probe (6) . While the 2114'' cell lines, Raji and
Daudi, strongly express exon A-containing LCA mRNAs, the 2114- cell line,
HSB-2, does not express theA exon (1) . The data presented in this paper suggest
that the LCA.6 and LCA.338 cDNAs encode the 220- and 200-kD LCA forms,
respectively, while the LCA.1 perhaps encodes the 180-kD LCA form . The
LCA.260 cDNA, however, can also encode an LCA molecule ofabout the same
size as the LCA.338, i.e ., 200 kD . If this is the case, the 200-kD band actually
contains at least two forms of LCA molecules, one with the 2114 epitope
(LCA.338) and the other without the 2114 epitope. To examine this possibility,
we did reciprocal preclearing experiments using 125I-labeled cell surface mole-
cules (Fig. 3) . The preclearing by the GAP 8.3, which reacts to all forms of the
LCA molecules, completely removed the anti-2114-reactive materials . The pre-
clearing by the anti-2114 antibody completely eliminated the highest molecular
weight (220 kD) protein from the GAP 8.3-reactive material, but a substantial
amount of the 200-kD protein still remained . Therefore, the 200-kD protein ofSTREULI ET AL.
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FIGURE 3 .
￿
Immunoprecipitation of cell sur-
face-labeled LCA molecules using anti-LCA
antibodies. Lysates of 'ssI-labeled cell-surface
molecules of T4' cells were precleared with
(1, 2) no antibody, (3, 4) GAP 8.3, or (5, 6)
anti-2H4, and then immunoprecipitated with
(1, 3, 5) GAP 8.3, or (2, 4, 6) anti-2H4 .
the GAP 8 .3 immunoprecipitate is indeed heterogeneous, and the second 200-
kD LCA molecule lacking the 2H4 epitope does exist . These results, as well as
the cDNA cloning, further demonstrate the complexity of the human LCA
system .
Summary
The anti-2H4 antibody, which subdivides the T4+ population of human T
lymphocytes into T4+, 2H4' suppressor-inducer cells and T4+, 2H4- helper
cells, recognizesan epitope on a subset of the human leukocyte common antigens
(LCAs) . LCAs are a family of cell surface glycoproteins generated from a single
gene by the differential usage of three exons near the NH2-terminus. Using
cDNA clones corresponding to four of the different forms of LCA molecules,
extracellular domains of the LCA molecules were synthesized in vitro . Immu-
noprecipitation of these molecules with the anti-2H4 antibody demonstrated that
exon A is required for the expression of the 2H4 epitope .
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